Biology and preclinical models of colorectal cancer metastasis
Open Access
- 31 October 2026
- journal article
- review article
- Published by Korean Association for the Study of Intestinal Diseases in Intestinal Research
- Vol. 24 (4) , 635-654
Abstract
Metastatic colorectal cancer (mCRC) is the principal cause of CRC-related mortality, yet the biology of mCRC remains only partly understood and challenging to interrogate experimentally. Despite recent progress in mapping recurrent genetic and epigenetic alterations and treatment responses of mCRC, these efforts provide limited insight into how heterogeneous primary tumors breach tissue barriers, survive in circulation, and colonize distant organs. In this review, we summarize current experimental systems for studying mCRC, including genetically engineered mouse models, carcinogen-induced and transplant models, and patient-derived organoid and xenograft platforms, and discuss how each captures or fails to capture key steps of the metastatic cascade and organ-specific microenvironments. We highlight practical obstacles to longitudinal sampling and quantitative readouts of metastatic burden, as well as conceptual gaps in modeling immune and stromal influences. Finally, we outline how emerging approaches, including single-cell and spatial transcriptomics, and advances in longitudinal tracking of metastatic burden could be combined into an integrated framework that more faithfully links mechanistic insight to clinical behavior and ultimately to metastasis-specific therapies.Keywords
Funding Information
- Cancer Prevention and Research Institute of Texas (RP200315)
- National Institutes of Health (CA278967)
- American Association for Cancer Research (25-40-60-SEO)
This publication has 191 references indexed in Scilit:
- Humanized mouse models: A valuable platform for preclinical evaluation of human cancerBiotechnology and Bioengineering, 2023
- Integrated analysis of single cell and bulk RNA sequencing identifies CTHRC1+INHBA+CAF as drivers of colorectal cancer progressionMolecular Carcinogenesis, 2023
- Patient‐derived xenograft model in colorectal cancer basic and translational researchAnimal Models and Experimental Medicine, 2022
- Crosstalk between metabolic reprogramming and epigenetics in cancer: updates on mechanisms and therapeutic opportunitiesCancer Communications, 2022
- A multi‐site metastasis‐on‐a‐chip microphysiological system for assessing metastatic preference of cancer cellsBiotechnology and Bioengineering, 2018
- Generation of a unique strain of multiple intestinal neoplasia (Apc+/Min‐FCCC) mice with significantly increased numbers of colorectal adenomasMolecular Carcinogenesis, 2005
- Tissue‐specific and inducible Cre‐mediated recombination in the gut epitheliumGenesis, 2004
- Validation of a model of colon cancer progressionThe Journal of Pathology, 2000
- Mouse 4T1 Breast Tumor ModelCurrent Protocols in Immunology, 2000
- Metastatic models of human cancer xenografted in the nude mouse: The importance of orthotopic transplantationJournal of Cellular Biochemistry, 1994